NVD-X3

N/A

Report date: 2024/08/27 14:18:43

Base Information

Drug NameNVD-X3
Drug Alias NameNVD-X3NVDX3
ClassificationBiologics
Mechanisms of ActionTissue replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal FusionRadius FracturesWounds and Injuries +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumLuxembourg
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovadip Biosciences SA
China Registration ClassN/A

Develop Information

Active CompaniesNovadip Biosciences SA
Inactive CompaniesN/A
Active IndicationsSpinal FusionRadius FracturesWounds and Injuries +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A